Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases
2017 Jan 31;17(1):5
August 2022: Judges centralized six Novo Nordisk lawsuits in multidistrict litigation in Delaware against generic drug makers for patent infringement
TB-500 contributes to these experimental systems through its well-characterized actin-binding properties
However, these findings are still awaiting further confirmation
US$ 28.12
US$ 20.28
US$ 27.02
US$ 24.52
US$ 20.40
